New Vanguard CEO says improving customer experience is a ‘very high’ priority and AI could help
Salim Ramji comes to Vanguard from rival BlackRock, making him the first outsider CEO for the roughly $9 trillion asset manager.
Yields on cash are likely to drop. Put money to work here instead, Janus Henderson says
For investors who need to get out of cash but have cold feet about adding duration, short-term bonds might be a nice incremental step.
U.S. crude oil falls nearly 2% as traders unfazed by Israel-Hezbollah escalation
A rocket attack threatens to spark war between Israel and Hezbollah.
Here are JPMorgan’s top drug stock picks into earnings
These are JPMorgan’s top drug picks heading into earnings.
This under-the-radar drug stock is undergoing a long-term turnaround, according to the charts
Katie Stockton breaks down the charts on Viatris.
Stocks making the biggest moves midday: Walt Disney, Dexcom, McDonald’s, On Semiconductor and more
These are the stocks posting the largest moves in midday trading.
AT&T, other phone companies sued over stolen nude images could face liability after court ruling
Companies like AT&T and T-Mobile have skirted liability when workers allegedly stole nude images from customer phones, but that may change after a court ruling.
French telecoms network hit by vandalism within days of arson attacks against national railways
Damage to French telecoms infrastructure was reported by officials early Monday, causing local power outages.
SoftBank-backed Ola Electric aims to raise $734 million in India’s biggest IPO this year
The Indian e-scooter maker will raise funds at at a sharply lower $4 billion valuation
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Swiss pharmaceutical giant Roche said Monday it is accelerating the timeline for its Wegovy rival weight loss drugs following promising early stage trial data.
